Clinical Trial Update: An Add-on Study of MLR-1023 in Adults With Uncontrolled Type 2 Diabetes on Metformin Therapy [Phase 2]

View source ↗

Summary

Phase 2 add-on trial of MLR-1023 in adults with uncontrolled type 2 diabetes on metformin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• MLR-1023 (MLR-1023)

Snippet

Sponsor: Melior Pharmaceuticals | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: UNKNOWN